SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
143 hedge funds and large institutions have $436M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
74% less call options, than puts
Call options by funds: $2M | Put options by funds: $7.67M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
143
Holding in Top 10
–
Calls
$2M
Puts
$7.67M
Top Buyers
| 1 | +$4.86M | |
| 2 | +$4.01M | |
| 3 | +$3.88M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.67M |
| 5 |
Goldman Sachs
New York
|
+$3.22M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$18.5M | |
| 3 | -$13.6M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$11.5M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$11.4M |